Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 101-120 of 311

Ref Title Date Issued Review
TA100 Colon cancer (adjuvant) - capecitabine and oxaliplatin (TA100) Apr 2006 TBC
TA110 Follicular lymphoma - rituximab (TA110) (replaced by TA243) Sep 2006 Jun 2009
TA112 Breast cancer (early) - hormonal treatments (TA112) Nov 2006 Jun 2009
TA101 Prostate cancer (hormone-refractory) - docetaxel (TA101) Jun 2006 Jun 2009
TA105 Colorectal cancer - laparoscopic surgery (review) (TA105) Aug 2006 Sep 2009
TA113 Diabetes (type 1 and 2) - inhaled insulin (withdrawn) (TA113) (withdrawn) Dec 2006 TBC
TA119 Leukaemia (lymphocytic) - fludarabine (TA119) Feb 2007 Oct 2009
TA91 Ovarian cancer (advanced) - paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan (review) (TA91) May 2005 TBC
TA88 Bradycardia - dual chamber pacemakers (TA88) Feb 2005 TBC
TA117 Hyperparathyroidism - cinacalcet (TA117) Jan 2007 Dec 2009
TA180 Psoriasis - ustekinumab (TA180) Sep 2009 Jan 2010
TA124 Lung cancer (non-small-cell) - pemetrexed (TA124) Aug 2007 Jan 2010
TA116 Breast cancer - gemcitabine (TA116) Jan 2007 Jan 2010
TA114 Drug misuse - methadone and buprenorphine (TA114) Jan 2007 TBC
TA115 Drug misuse - naltrexone (TA115) Jan 2007 TBC
TA77 Insomnia - newer hypnotic drugs (TA77) Apr 2004 TBC
TA144 Obesity - rimonabant (withdrawn) (TA144) (withdrawn) Jun 2008 Apr 2010
TA122 Ischaemic stroke (acute) - alteplase (TA122) (replaced by TA264) Jun 2007 TBC
TA123 Smoking cessation - varenicline (TA123) Jul 2007 TBC
TA152 Coronary artery disease - drug-eluting stents (TA152) Jul 2008 TBC

This page was last updated: 23 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.